Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+48Malignant Bladder Neoplasm+24Malignant Laryngeal Neoplasm+24Cutaneous Melanoma+20Malignant Esophageal Neoplasm+16Malignant Pancreatic Neoplasm+16Malignant Salivary Gland Neop…+16Malignant Prostate Neoplasm+12Malignant Mesothelioma+8Malignant Kidney Neoplasm+4Malignant Liver Neoplasm+4Malignant Testicular Neoplasm+4Malignant Lung Neoplasm0Malignant Penile Neoplasm0Malignant Thyroid Gland Neopl…0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+48100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21593
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
88
activityPercentile
40

ranking row 2603537

2▲3Malignant Bladder Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11978
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
72
activityPercentile
48

ranking row 2603539

2▲1Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3016
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2603538

4=Cutaneous Melanoma+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5295
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
44
activityPercentile
24

ranking row 2603540

5▲4Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12297
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2603541

5▲8Malignant Pancreatic Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23177
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
92
activityPercentile
76

ranking row 2603542

5▲3Malignant Salivary Gland Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
639
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
28
activityPercentile
12

ranking row 2603543

8▲9Malignant Prostate Neoplasm+1272Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
31488
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2603544

9▼2Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1864
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2603545

10▲6Malignant Kidney Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9188
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56

ranking row 2603546

10▲10Malignant Liver Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
18593
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
84
activityPercentile
80

ranking row 2603547

10▲1Malignant Testicular Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
401
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
8
activityPercentile
4

ranking row 2603548

13▲9Malignant Lung Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
76233
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2603549

13▲2Malignant Penile Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
347
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
4
activityPercentile
4

ranking row 2603551

13▲11Malignant Thyroid Gland Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
919
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
32
activityPercentile
32

ranking row 2603550

16▲3Malignant Rectal Neoplasm-440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6371
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
48
activityPercentile
52

ranking row 2603552

17▲9Leukemia-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13732
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
88

ranking row 2603553

17▲5Malignant Anal Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
466
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
12
activityPercentile
20

ranking row 2603556

17▲9Malignant Central Nervous System Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9731
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
64
activityPercentile
72

ranking row 2603554

17▲4Malignant Hypopharyngeal Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
319
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
0
activityPercentile
8

ranking row 2603555

21▲9Hodgkin Lymphoma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
614
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
24
activityPercentile
36

ranking row 2603557

21▲5Malignant Gastric Neoplasm-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6628
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
52
activityPercentile
64

ranking row 2603558

21▲8Multiple Myeloma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6764
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56
activityPercentile
68

ranking row 2603559

24▲8Malignant Nasopharyngeal Neoplasm-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
541
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
20
activityPercentile
44

ranking row 2603561

24▲7Non-Hodgkin Lymphoma-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11678
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
68
activityPercentile
92

ranking row 2603560

26▲10Malignant Breast Neoplasm-800Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
484
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
16
activityPercentile
96

ranking row 2603562

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 99825c2998dde870563ffeff